Funder: Pfizer Inc.
Due Dates: March 31, 2026 (Full proposal submission deadline)
Funding Amounts: $150,000–$250,000 per project (includes $50,000 ASCP PDI fee); total program funding up to $1.5 million; project duration ~18 months
Summary: Funds multidisciplinary quality improvement projects to optimize molecular testing and care coordination for metastatic colorectal cancer using data-driven approaches and ASCP's benchmarking platform.
Key Information: Requires two PIs (pathologist and oncologist); ASCP membership required for pathologist PI/co-PI; proposals must include $50,000 PDI platform fee in budget.